Research News

A team of researchers at GW Cancer Center found that T-cells lacking in the HDAC11 enzyme performed better in attacking cancer tumor cells. This research highlights the importance of treating HDAC11 as an immunotherapeutic target.

Norman Lee, PhD, professor of pharmacology and physiology, published research in Nature Communications finding that a form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.

When chronic, unresponsive eruptions don't respond to standard treatments, think cutaneous T-cell lymphoma, says L. Frank Glass, MD in an interview with Adam Friedman, MD.

WASHINGTON (June 14, 2017) - Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment.

Adam Friedman, M.D., Associate Professor of Dermatology at the GW School of Medicine and Health Sciences, wrote an article for the Huffington Post on avoiding ultraviolet radiation.

George Washington University (GW) researchers received a $2.2 million grant from the National Cancer Institute to uncover why certain cancer types increase whereas others are unchanged or even decrease in those with HIV infection.